Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +46.08%
#3 Glidr Glidr +35.94%
#4 Cysic Cysic +32.50%
#5 Walrus Walrus +23.65%
#6 Tutorial Tutorial +23.18%
#7 Enso Enso +18.12%
#8 Humanity Humanity +18.02%
#9 Codatta Codatta +14.33%
#10 Huma Finance Huma Finance +13.74%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Clasificación en acciones #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Precio por acción
$0.6
Última sincronización: 2024-08-14
Capitalización bursátil
$2.09M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
SG
Comercio ASLAN Pharmaceuticals Limited (ASLN)

Categoría

Healthcare
Número de acciones en circulación de ASLAN Pharmaceuticals Limited (ASLN)
Número de acciones en circulación al March 2024: 4.67M
Según los últimos informes financieros y el precio de las acciones de ASLAN Pharmaceuticals Limited, el número actual de acciones en circulación es 4.67M. Al final de December 2022, la empresa tenía 3.49M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de ASLAN Pharmaceuticals Limited (ASLN) desde 2014 hasta 2026
Acciones en circulación al final de cada año
Año Acciones en circulación Cambiar
2026 (TTM) 4.67M 13.50%
2023 4.11M 17.93%
2022 3.49M 7.07%
2021 3.26M 69.43%
2020 1.92M 18.37%
2019 1.62M 8.45%
2018 1.50M 20.35%
2017 1.24M -4.34%
2016 1.30M 136.41%
2015 550.22K 761.10%
2014 63.90K 0.00%
Acciones en circulación de empresas similares o competidores
Empresa Acciones en circulación Diferencia País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 5,339.61%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 1,232.28%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE